La Colina has very qualified generic R&D team committed to bring science and innovation to provide high quality generic medicine that improve people’s lives.
La Colina pursuing technological supremacy in a wide range of dosage forms, (Oral liquid and solid dosage, injectable solutions and suspensions, nasal drops, ophthalmic preparations, creams, gels and ointments), drug delivery technologies (Mixed micelles, inclusion complexes, nanosuspensions, liposomes, solid lipid nanoparticles, lyophilization) and therapeutic areas.
R&D team has a good understanding of intellectual property landscape that enabled La Colina shifted from localizing products to product development.